| Revenues & operating earnings (IFRSs) |
|
|
| € million |
Q1/07 |
Q2/07 |
Q3/07 |
9M/07 |
Q4/07 |
2007 |
Q1/08 |
Q2/08 |
Q3/08 |
9M/08 |
| Potash and Magnesium Products |
368.5 |
339.7 |
313.5 |
1,021.7 |
386.3 |
1,408.0 |
522.5 |
612.8 |
763.4 |
1,898.7 |
| COMPO |
217.1 |
156.9 |
115.9 |
489.9 |
127.5 |
617.4 |
275.9 |
205.0 |
169.2 |
650.1 |
| fertiva |
150.5 |
154.0 |
164.0 |
468.5 |
179.5 |
648.0 |
212.5 |
228.8 |
346.4 |
787.7 |
| Salt |
176.6 |
98.6 |
101.0 |
376.2 |
168.9 |
545.1 |
170.3 |
108.0 |
131.0 |
409.3 |
| Complementary Business Segments |
31.9 |
29.3 |
32.5 |
93.7 |
31.4 |
125.1 |
31.7 |
29.6 |
31.2 |
92.5 |
| Reconciliation |
0.1 |
0.1 |
0.2 |
0.4 |
0.1 |
0.5 |
0.1 |
0.3 |
0.2 |
0.6 |
| K+S Group revenues |
944.7 |
778.6 |
727.1 |
2,450.4 |
893.7 |
3,344.1 |
1,213.0 |
1,184.5 |
1,441.4 |
3,838.9 |
| Potash and Magnesium Products |
52.8 |
55.9 |
65.0 |
173.7 |
4.2 |
177.9 |
170.9 |
291.4 |
465.6 |
927.9 |
| COMPO |
19.2 |
9.0 |
– |
28.2 |
3.8 |
32.0 |
35.9 |
29.1 |
24.7 |
89.7 |
| fertiva |
4.4 |
5.5 |
5.2 |
15.1 |
10.2 |
25.3 |
6.7 |
14.9 |
15.3 |
36.9 |
| Salt |
25.0 |
1.7 |
3.2 |
29.9 |
17.9 |
47.8 |
14.7 |
(4.2) |
8.5 |
19.0 |
| Complementary Business Segments |
10.0 |
8.0 |
11.9 |
29.9 |
7.8 |
37.7 |
7.1 |
7.1 |
5.1 |
19.3 |
| Reconciliation |
(8.1) |
(10.7) |
(5.9) |
(24.7) |
(10.3) |
(35.0) |
(9.0) |
(11.9) |
(17.0) |
(37.9) |
| K+S Group EBIT I |
103.3 |
69.4 |
79.4 |
252.1 |
33.6 |
285.7 |
226.3 |
326.4 |
502.2 |
1,054.9 |
| |
|
|
|
|
|
|
|
|
|
|
| Income statements (IFRSs) |
|
|
| € million |
Q1/07 |
Q2/07 |
Q3/07 |
9M/07 |
Q4/07 |
2007 |
Q1/08 |
Q2/08 |
Q3/08 |
9M/08 |
| Revenues |
944.7 |
778.6 |
727.1 |
2,450.4 |
893.7 |
3,344.1 |
1,213.0 |
1,184.5 |
1,441.4 |
3,838.9 |
| Cost of sales |
624.6 |
533.1 |
472.2 |
1,629.9 |
582.1 |
2,212.0 |
711.5 |
635.4 |
737.3 |
2,084.2 |
| Gross profit |
320.1 |
245.5 |
254.9 |
820.5 |
311.6 |
1,132.1 |
501.5 |
549.1 |
704.1 |
1,754.7 |
| Selling expenses |
203.7 |
181.8 |
162.7 |
548.2 |
204.1 |
752.3 |
216.0 |
194.5 |
178.6 |
589.1 |
| General and administrative expenses |
20.1 |
25.4 |
19.1 |
64.6 |
24.8 |
89.4 |
23.1 |
28.0 |
25.8 |
76.9 |
| Research and development costs |
4.0 |
3.5 |
3.9 |
11.4 |
4.1 |
15.5 |
4.3 |
4.3 |
4.6 |
13.2 |
| Other operating income/expenses |
10.8 |
34.4 |
6.3 |
51.5 |
(45.3) |
6.2 |
(32.0) |
3.7 |
6.2 |
(22.1) |
| Income from investments, net |
0.2 |
0.2 |
3.9 |
4.3 |
0.3 |
4.6 |
0.2 |
0.4 |
0.9 |
1.5 |
| Operating earnings (EBIT I) |
103.3 |
69.4 |
79.4 |
252.1 |
33.6 |
285.7 |
226.3 |
326.4 |
502.2 |
1,054.9 |
| Market value changes from hedging transactions |
3.0 |
9.0 |
(233.5) |
(221.5) |
(171.1) |
(392.6) |
(107.7) |
(6.8) |
(34.1) |
(148.6) |
| Earnings after market value changes (EBIT II) |
106.3 |
78.4 |
(154.1) |
30.6 |
(137.5) |
(106.9) |
118.6 |
319.6 |
468.1 |
906.3 |
| Financial result |
(9.8) |
(6.3) |
(8.4) |
(24.5) |
(11.2) |
(35.7) |
(2.3) |
(11.9) |
(8.1) |
(22.3) |
| Earnings before income taxes |
96.5 |
72.1 |
(162.5) |
6.1 |
(148.7) |
(142.6) |
116.3 |
307.7 |
460.0 |
884.0 |
| Earnings before income taxes, adjusted 1) |
93.5 |
63.1 |
71.0 |
227.6 |
22.4 |
250.0 |
224.0 |
314.5 |
494.1 |
1,032.6 |
| Taxes on income |
31.9 |
24.2 |
(54.1) |
2.0 |
(51.5) |
(49.5) |
31.5 |
81.4 |
126.3 |
239.2 |
| - of which deferred taxes |
4.6 |
6.5 |
(42.2) |
(31.1) |
(37.8) |
(68.9) |
12.9 |
27.2 |
5.9 |
46.0 |
| Minority interests in earnings |
0.1 |
– |
– |
0.1 |
0.1 |
0.2 |
– |
0.1 |
0.2 |
0.3 |
| Group earnings after taxes and minority interests |
64.5 |
47.9 |
(108.4) |
4.0 |
(97.3) |
(93.3) |
84.8 |
226.2 |
333.5 |
644.5 |
| Group earnings after taxes, adjusted 1) |
62.6 |
42.2 |
47.6 |
152.4 |
22.9 |
175.3 |
162.6 |
231.1 |
358.1 |
751.8 |
| |
|
|
|
|
|
|
|
|
|
|
| Other key data (IFRSs) |
|
|
| |
Q1/07 |
Q2/07 |
Q3/07 |
9M/07 |
Q4/07 |
2007 |
Q1/08 |
Q2/08 |
Q3/08 |
9M/08 |
| Capital expenditure (€ million) 2) |
25.2 |
25.6 |
45.4 |
96.2 |
75.4 |
171.6 |
24.2 |
60.5 |
48.4 |
133.1 |
| Depreciation and amortisation (€ million) 2) |
31.0 |
31.0 |
31.2 |
93.2 |
35.0 |
128.2 |
32.5 |
33.8 |
39.1 |
105.4 |
| Gross cash flow (€ million) |
104.1 |
67.1 |
116.5 |
287.7 |
84.4 |
372.1 |
243.0 |
281.5 |
456.8 |
981.3 |
| Net debt (€ million) |
713.1 |
741.6 |
– |
830.3 |
– |
1,086.5 |
1,002.8 |
904.4 |
– |
633.6 |
| Earnings per share, adjusted (€ ) 1), 3) |
0.38 |
0.26 |
0.29 |
0.92 |
0.14 |
1.06 |
0.99 |
1.40 |
2.17 |
4.56 |
| Gross cash flow per share (€) 3) |
0.63 |
0.40 |
0.71 |
1.74 |
0.51 |
2.25 |
1.47 |
1.71 |
2.77 |
5.95 |
| Book value per share, adjusted (€) 1), 3) |
6.74 |
6.52 |
– |
6.65 |
– |
6.80 |
6.03 |
6.71 |
– |
9.04 |
| Total number of shares (million) 3) |
165.00 |
165.00 |
– |
165.00 |
– |
165.00 |
165.00 |
165.00 |
– |
165.00 |
| Number of shares outstanding (million) 3), 4) |
164.76 |
165.00 |
– |
165.00 |
– |
165.00 |
164.84 |
165.00 |
– |
165.00 |
| Average number of shares (million) 3), 5) |
164.84 |
164.92 |
165.00 |
164.92 |
165.00 |
164.96 |
164.95 |
164.95 |
165.00 |
164.93 |
| Closing price (XETRA, €) 3) |
20.59 |
28.52 |
– |
32.14 |
– |
40.69 |
51.83 |
91.58 |
– |
48.64 |
| Employees as of the reporting date (number) |
11,956 |
11,912 |
– |
11,980 |
– |
12,033 |
12,141 |
12,145 |
– |
12,323 |
| |
|
|
|
|
|
|
|
|